| 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set … MM Kittleson, GS Panjrath, K Amancherla, LL Davis, A Deswal, DL Dixon, ... Journal of the American College of Cardiology 81 (18), 1835-1878, 2023 | 142 | 2023 |
| 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of … Writing Committee Members, SS Virani, LK Newby, SV Arnold, V Bittner, ... Journal of the American College of Cardiology 82 (9), 833-955, 2023 | 320 | 2023 |
| 2363: Ventriculo-arterial coupling and left ventricular mechanical work in systolic and diastolic heart failure L Buckley, S Carbone, C Trankle, MM Viscusi, J Regan, D Dixon, ... Journal of Clinical and Translational Science 1 (S1), 36-36, 2017 | | 2017 |
| 2544: Dietary polyunsaturated fatty acid consumption is associated with improved body composition in nonalcoholic steatohepatitis patients H Billingsley, S Carbone, L Buckley, DL Dixon, D Kadariya, S Dessie, ... Journal of Clinical and Translational Science 1 (S1), 38-38, 2017 | | 2017 |
| 5947 Predictive role of C-reactive protein levels in patients with ST-segment elevation acute myocardial infarction for heart failure related events B Van Tassell, CR Trankle, D Kadariya, JM Canada, S Carbone, ... European Heart Journal 40 (Supplement_1), ehz746. 0097, 2019 | | 2019 |
| A bibliometric analysis of peer-reviewed journal publications of pharmacy practice department chairs DL Dixon, DM Sobieraj, RE Brown, RA Koenig, M Wagner, WL Baker American Journal of Pharmaceutical Education 85 (8), 8481, 2021 | 4 | 2021 |
| A case report of complete warfarin resistance and clinical application of pharmacogenetic testing. E Parod, D Dixon, E Sisson, K Ogbonna PHARMACOTHERAPY 36 (12), E297-E297, 2016 | | 2016 |
| A focused update to the 2019 NLA scientific statement on use of lipoprotein (a) in clinical practice ML Koschinsky, A Bajaj, MB Boffa, DL Dixon, KC Ferdinand, SS Gidding, ... Journal of clinical lipidology 18 (3), e308-e319, 2024 | 10 | 2024 |
| A Journal on Heart and Vascular Diseases M LOMBARDI, JG CHIABRANDO, GM VESCOVO, E BRESSI, ... Minerva Cardioangiologica 68 (1), 47-50, 2020 | | 2020 |
| A modified approach to setting curriculum boundaries in pharmacy school DS Longyhore, DL Dixon, ZR Noel American Journal of Pharmaceutical Education 82 (9), 7010, 2018 | 11 | 2018 |
| A prescription for prescribing: ensuring continued pharmacist preparedness KM Zimmerman, TM Salgado, JVR Goode, EM Sisson, DL Dixon Annals of Pharmacotherapy 52 (7), 697-699, 2018 | 5 | 2018 |
| A review of PCSK9 inhibition and its effects beyond LDL receptors DL Dixon, C Trankle, L Buckley, E Parod, S Carbone, BW Van Tassell, ... Journal of clinical lipidology 10 (5), 1073-1080, 2016 | 56 | 2016 |
| A stepwise approach to prescribing novel lipid-lowering medications H Kakavand, M Aghakouchakzadeh, A Shahi, SS Virani, DL Dixon, ... Journal of clinical lipidology 16 (6), 822-832, 2022 | 2 | 2022 |
| A trial of blood-pressure reduction in black barbershops. EM Sisson, DL Dixon, AW Dow The New England journal of medicine 379 (2), 200-200, 2018 | 4 | 2018 |
| Abstract P436: The Role of Free Fatty Acids in Patients With Obesity and Heart Failure With Preserved Ejection Fraction: A Post-hoc Analysis of the UFA-preserved Pilot Study H Billingsley, JM Canada, R Markley, B Rotelli, D Kadariya, N Potere, ... Circulation 141 (Suppl_1), AP436-AP436, 2020 | 1 | 2020 |
| ACE-Inhibitors in Hypertension: A historical perspective and current insights S Cutrell, IS Alhomoud, A Mehta, AH Talasaz, B Van Tassell, DL Dixon Current hypertension reports 25 (9), 243-250, 2023 | 16 | 2023 |
| Additive manufacturing of pharmaceuticals for precision medicine applications: A review of the promises and perils in implementation M Trivedi, J Jee, S Silva, C Blomgren, VM Pontinha, DL Dixon, ... Additive Manufacturing 23, 319-328, 2018 | 68 | 2018 |
| Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center C Tran, V Vo, P Taylor, DA Koehn, SS Virani, DL Dixon Journal of clinical lipidology 16 (4), 491-497, 2022 | 7 | 2022 |
| Adherence to Lipid Monitoring Recommendations at an Academic Medical Center C Tran, V Vo, P Taylor, D Dixon 2021 ACCP VIRTUAL Annual Meeting, 2021 | | 2021 |
| AN INTERDISCIPLINARY APPROACH TO MANAGING SEVERE HYPERLIPIDEMIA DUE TO RUXOLITINIB THERAPY IN A PATIENT WITH GRAFT VERSUS HOST DISEASE OF THE LIVER DL Dixon, G Simmons, L Rodriguez, A Abbate Journal of the American College of Cardiology 75 (11_Supplement_1), 2298-2298, 2020 | | 2020 |
Benjamin Van TassellVirginia Commonwealth University在 vcu.edu 的电子邮件经过验证
